Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pivotal In-Office Clinical Study of the Solo+ Tympanostomy Tube Device

NCT05741333 is registered in ClinicalTrials.gov with AventaMed DAC as lead sponsor.

NCT NCT05741333
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05741333 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pivotal In-Office Clinical Study of the Solo+ Tympanostomy Tube Device
Lead sponsor
AventaMed DAC
Phase
Not applicable
Overall status
Active, not recruiting
Start date
March 30, 2023
Completion date
March 31, 2028
Enrollment
66 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

ear infection, otitis media